N-[6-[5-(4-fluorophenyl)-2,3-dimethylimidazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]-2-methyl-3-pyridin-3-ylbenzamide
C30H24FN7O — CID 118539001
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[6-[5-(4-fluorophenyl)-2,3-dimethylimidazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]-2-methyl-3-pyridin-3-ylbenzamide
N-[6-[5-(4-fluorophenyl)-2,3-dimethylimidazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]-2-methyl-3-pyridin-3-ylbenzamide (PubChem CID 118539001) has the molecular formula C30H24FN7O and a molecular weight of 517.57 g/mol. Its IUPAC name is N-[6-[5-(4-fluorophenyl)-2,3-dimethylimidazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]-2-methyl-3-pyridin-3-ylbenzamide.
Molecular Properties
| Compound Name | N-[6-[5-(4-fluorophenyl)-2,3-dimethylimidazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]-2-methyl-3-pyridin-3-ylbenzamide |
|---|---|
| PubChem CID | 118539001 |
| Molecular Formula | C30H24FN7O |
| Molecular Weight | 517.57 g/mol |
| Exact Mass | 517.20 |
| IUPAC Name | N-[6-[5-(4-fluorophenyl)-2,3-dimethylimidazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]-2-methyl-3-pyridin-3-ylbenzamide |
| SMILES | Cc1c(C(=O)Nc2cn3nc(-c4c(-c5ccc(F)cc5)nc(C)n4C)ccc3n2)cccc1-c1cccnc1 |
| InChI | InChI=1S/C30H24FN7O/c1-18-23(21-6-5-15-32-16-21)7-4-8-24(18)30(39)35-26-17-38-27(34-26)14-13-25(36-38)29-28(33-19(2)37(29)3)20-9-11-22(31)12-10-20/h4-17H,1-3H3,(H,35,39) |
| InChIKey | AYWMPSJRMAWGTF-UHFFFAOYSA-N |
| XLogP | 5.87 |
| TPSA | 90.00 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 517.57 |
| LogP ≤ 5 | 5.87 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118539001 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.